Trilogy's Buglass takes advantage of near-record price to sell shares as first tranche of options vest

Trilogy's Buglass takes advantage of near-record price to sell shares as first tranche of options vest
Jonathan Underhill
By Jonathan Underhill March 29 (BusinessDesk) -  Trilogy International chief executive Angela Buglass has sold 100,000 shares after the first tranche of 400,000 options vested, taking advantage of a stock price that soared 284 percent in the past year and reached a record this month. Buglass sold shares this month at prices ranging from $3.30 to $3.469, for a total of $344,763, according to a disclosure notice from the Auckland-based skincare and home fragrance company. She was issued with 400,000 options at an exercise price of 60 cents...